Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Michael G. Tovey"'
Autor:
Christophe Lallemand, Rosa Ferrando-Miguel, Michael Auer, Sarah Iglseder, Theresa Czech, Anouk Gaber-Wagener, Franziska Di Pauli, Florian Deisenhammer, Michael G. Tovey
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Highly sensitive reporter-gene assays have been developed that allow both the direct vascular endothelial growth factor (VEGF) neutralizing activity of bevacizumab and the ability of bevacizumab to activate antibody dependent cellular cytotoxicity (A
Externí odkaz:
https://doaj.org/article/fa27d00b517643a3bae672aa94686f2a
Autor:
Christophe Lallemand, Feifei Liang, Flore Staub, Maud Simansour, Benoit Vallette, Lue Huang, Rosa Ferrando-Miguel, Michael G. Tovey
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Novel ADCC effector cells expressing the V-variant or F-variant of FcγRIIIa (CD16a) and firefly luciferase under the control of a chimeric promoter incorporating recognition sequences for the principal transcription factors involved in FcγRIIIa sig
Externí odkaz:
https://doaj.org/article/d64915da9b914ef28ce21a669e7787eb
Autor:
Michael G. Tovey, Christophe Lallemand
Publikováno v:
Pharmaceuticals, Vol 3, Iss 4, Pp 1162-1186 (2010)
Interferons (IFNs) are class II cytokines that are key components of the innate immune response to virus infection. Three IFN sub-families, type I, II, and III IFNs have been identified in man, Recombinant analogues of type I IFNs, in particular IFN
Externí odkaz:
https://doaj.org/article/4fbd201cd7c34645bb86acb2fc96b894
Autor:
Michael G. Tovey, Benoit Vallette, Huang Lue, Rosa Ferrando-Miguel, Maud Simansour, Feifei Liang, Christophe Lallemand, Flore Staub
Publikováno v:
Journal of Immunology Research, Vol 2017 (2017)
Journal of Immunology Research
Journal of Immunology Research
Novel ADCC effector cells expressing the V-variant or F-variant of FcγRIIIa (CD16a) and firefly luciferase under the control of a chimeric promoter incorporating recognition sequences for the principal transcription factors involved in FcγRIIIa sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24836bdc83240244db957568c67b49dc
https://doi.org/10.1155/2017/3908289
https://doi.org/10.1155/2017/3908289
Autor:
Michael G. Tovey, Corinne Desaint, Odile Launay, Bénédicte Charmeteau, J.-F. Meritet, Pierre Lebon, Frédéric Bloch
Publikováno v:
European Cytokine Network. 27:63-67
To investigate the relationship between the response to influenza vaccination and the ability to produce proinflamatory cytokines in elderly subjects.Whole blood samples from 25 elderly subjects collected before influenza vaccination were stimulated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b6c3fd8eab8429b7b56493413b7c05
https://doi.org/10.1684/ecn.2016.0378
https://doi.org/10.1684/ecn.2016.0378
Autor:
Chittappen K. Prajeeth, Martin Stangel, Siegfried Weiss, Chintan Chhatbar, Dirk Schlüter, Julia Spanier, Stefan Lienenklaus, Claudia Soldner, Ulrich Kalinke, Claudia N. Detje, Michael G. Tovey
Publikováno v:
Journal of Virology. 89:2731-2738
Previously we found that following intranasal (i.n.) infection with neurotropic vesicular stomatitis virus (VSV) type I interferon receptor (IFNAR) triggering of neuroectodermal cells was critically required to constrain intracerebral virus spread. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550ddc373073f3fb0354693ae0679132
https://doi.org/10.1128/jvi.02044-14
https://doi.org/10.1128/jvi.02044-14
Autor:
Mark A. Ainsworth, Michael G. Tovey, Ole Østergaard Thomsen, Tobias Wirenfeldt Klausen, Casper Steenholdt, Jørn Brynskov, Klaus Bendtzen
Publikováno v:
Therapeutic Drug Monitoring. 35:530-538
Several techniques are used to measure infliximab (IFX) and anti-IFX antibodies (Abs) in Crohn's disease. The aim of this study was to compare different assays for this purpose.Fluid-phase radioimmunoassay (RIA), solid-phase enzyme-linked immunosorbe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d28e43226488fc1bd0429db14408e06
https://doi.org/10.1097/ftd.0b013e31828d23c3
https://doi.org/10.1097/ftd.0b013e31828d23c3
Autor:
Michael G. Tovey, Christophe Lallemand
Publikováno v:
Bioanalysis. 4:2179-2190
Biopharmaceuticals are used extensively for the treatment of a number of chronic debilitating and fatal diseases such as cancer and inflammatory or autoimmune diseases. Although biopharmaceuticals are in general well tolerated, the development of ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ab374917f16d9cd61afff5e7392ef67
https://doi.org/10.4155/bio.12.186
https://doi.org/10.4155/bio.12.186
Autor:
Christophe Lallemand, Michael G. Tovey
Publikováno v:
Therapeutic Advances in Drug Safety. 2:113-128
Biopharmaceuticals are used widely for the treatment of cancer, chronic viral hepatitis, inflammatory, and autoimmune diseases. Biopharmaceuticals such as interferons are well tolerated for the most part with the most common adverse events observed b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f2ee054e5c0bf256a5f1d4dc69960f2
https://doi.org/10.1177/2042098611406318
https://doi.org/10.1177/2042098611406318
Autor:
Robbert van der Most, Sathish Mahendran, S. Broomfield, Bruce W. S. Robinson, Mark J. Smyth, Andrew J. Currie, Michael G. Tovey, Amy Prosser
Publikováno v:
The Journal of Immunology. 182:5217-5224
Topical application of tumors with the TLR7 agonist imiquimod is an effective adjunct treatment for a range of primary dermatological cancers. However, for therapy to be effective against a broad range of solid tumor types, it must promote a strong s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0d479d25799af5b85db0edb5e36b62
https://doi.org/10.4049/jimmunol.0803826
https://doi.org/10.4049/jimmunol.0803826